• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Endocr Connect . Low muscle mass and high visceral fat mass predict mortality in patients hospitalized with moderate-to-severe COVID-19: a prospecti

tetano

Editor, Senior Moderator
Endocr Connect


. 2022 Aug 1;EC-22-0290.
doi: 10.1530/EC-22-0290. Online ahead of print.
Low muscle mass and high visceral fat mass predict mortality in patients hospitalized with moderate-to-severe COVID-19: a prospective study


Fabyan Esberard de Lima Beltrão[SUP] 1 [/SUP], Daniele Carvalhal de Almeida Beltrão[SUP] 2 [/SUP], Giulia Carvalhal[SUP] 3 [/SUP], Fabyo Napoleão de Lima Beltrão[SUP] 4 [/SUP], Igor Motta de Aquino[SUP] 5 [/SUP], Thaíse da Silva Brito[SUP] 6 [/SUP], Barbara Costa Paulino[SUP] 7 [/SUP], Elisa Aires[SUP] 8 [/SUP], Diana Viegas[SUP] 9 [/SUP], Fabio Hecht[SUP] 10 [/SUP], Bruno Halpern[SUP] 11 [/SUP], Liana Clebia De Morais Pordeus[SUP] 12 [/SUP], Maria da Conceição Rodrigues Gonçalves[SUP] 13 [/SUP], Helton Estrela Ramos[SUP] 14 [/SUP]



Affiliations

Abstract

Introduction: The severity of coronavirus disease 2019 (COVID-19) has been positively correlated with several comorbidities. The primary outcome of the study was to assess the relationship between the mortality and severity of COVID-19 and obesity classes according to body mass index (BMI), visceral (VAT), subcutaneous adipose tissue area (SAT), muscle area (MA), and leptin levels.
Methods: In this prospective cohort study, 200 patients hospitalized with moderate-to-severe COVID-19 underwent an unenhanced computed tomography (CT) of the thorax, laboratory tests, and leptin levels between June and August 2020 were obtained.
Results: Our study included two hundred patients [male 52%; mean age: 62 (49-74) years; obesity (BMI > 30): 51,5%)]. Fifty-eight patients (23.5%) were admitted to the intensive care unit, and 29 (14.5%) died. In multivariate logistic regression (corrected for leptin, sex, age, serum biomarkers) and ROC curve, high VAT > 150 cm² (odds ratio [OR]: 6.15; P < 0.002), MA < 92 cm² (OR: 7.94; P < 0.005), and VAT/MA ratio > 2 (OR: 13.9; P < 0.0001) were independent risk factors for mortality. Indeed, the Kaplan-Meier curves showed that patients with MA < 92 cm² and without obesity (BMI < 30) had a lower survival rate (HR between 3.89 and 9.66; p < 0.0006) than the other groups. Leptin levels were not related to mortality and severity.
Conclusion: This prospective study reports data on the largest number of hospitalized severe COVID-19 patients and pinpoints visceral adipose tissue and muscle area calculated by CT as predictors of COVID-19 mortality.
 
Back
Top Bottom